英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
praesertim查看　praesertim　在百度字典中的解释百度英翻中〔查看〕
praesertim查看　praesertim　在Google字典中的解释Google英翻中〔查看〕
praesertim查看　praesertim　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home Page | Zirabev™ (bevacizumab-bvzr) HCP Website | Safety Info
    ZIRABEV, in combination with carboplatin and paclitaxel, is indicated for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC)
  • Zirabev Uses, Side Effects Warnings - Drugs. com
    What is Zirabev? Zirabev is used in adults alone or in combination with other cancer treatments to treat a certain type of brain tumor and certain types of cancers of the kidney, liver, lung, colon, rectum, cervix, ovary, or fallopian tube
  • Zirabev (bevacizumab): Uses, Side Effects, Dosage Reviews
    Learn about Zirabev (bevacizumab) usage and dosing Read the latest news and reviews about the drug as well as potential side effects and popular alternatives
  • ZIRABEV (bevacizumab-bvzr) Dosage and Administration - Medical
    Do not administer ZIRABEV until at least 28 days following major surgery and until adequate wound healing 2 2 Metastatic medication page for healthcare professionals to search for scientific information on Pfizer medications
  • label - Food and Drug Administration
    ZIRABEV, in combination with carboplatin and paclitaxel, is indicated for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non–squamous non–small
  • Zirabev - Chemocare
    It works by blocking a protein that causes cancer cells to grow and multiply This helps to slow or stop the spread of cancer cells It is a monoclonal antibody This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions
  • Zirabev®
    Zirabev is administered in addition to platinum-based chemotherapy for up to 6 cycles of treatment followed by Zirabev as a single agent until disease progression The recommended dose of Zirabev is 7 5 mg kg or 15 mg kg of body weight given once every 3 weeks as an intravenous infusion
  • Zirabev - European Medicines Agency (EMA)
    Zirabev is used in combination with other cancer medicines, depending on previous treatments or the presence of mutations (genetic changes) in the cancer that affect how well particular medicines work Zirabev contains the active substance bevacizumab and it is a ‘ biosimilar medicine ’
  • Zirabev: What Is It and How Does It Work? - AmeriPharma™ Specialty Care
    Zirabev is an anticancer drug with an active component, “bevacizumab-bvzr ” It is used to treat several types of cancer and belongs to the class of vascular endothelial growth factor (VEGF) inhibitors that targets VEGF proteins and blocks their activity
  • Zirabev (Bevacizumab-bvzr Injection): Side Effects, Uses . . . - RxList
    Zirabev (Bevacizumab-bvzr Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources





中文字典-英文字典  2005-2009